Embolisation of cancer: What is the evidence?

Cancer Imaging

Volumn 4, Issue 2, 2004, Pages 133-141

  Goode, J A ^a   Matson, M B ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Cancer; Chemoembolisation; Embolisation; Hepatocellular carcinoma

Indexed keywords

EID: 77956650910     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2004.0021     Document Type: Article

References (69)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
2. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-1994. Lancet 1997; 350: 1142-3.
3. Ramsey DE, Kernagis LY, Soulen MC, Geschwind J-FH. Chemoembolization of hepatocellular carcinoma. J Vasc Intervent Radiol 2002; 13: S211-21.
4. Geschwind J-FH. Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Intervent Radiol 2002; 13: 991-4.
5. Kamada K, Nakanishi T, Kitamoto M et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Intervent Radiol 2001; 12: 847-54.
6. Llado L, Virgili J, Figueras J et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 2000; 88(1): 50-7.
7. Hatanaka Y, Yamashita Y, Takahashi M et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995; 195(3): 747-52.
8. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M. Transcatheter arterial chemoembolization therapy using iodised oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000; 88(7): 1574-81.
9. Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 1256-61.
10. Bruix J, Llovet JM, Castells A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomised trial in a single institution. Hepatology 1998; 27(6): 1578-83.
11. Pelletier G, Ducreux M, Gay F et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomised trial. Groupe CHC. J Hepatol 1998; 29(1): 129-34.
12. Bayraktar Y, Balkanci F, Kayhan B et al. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma. Hepato-gastroenterology 1996; 43(9): 681-7.
13. Lo C-M, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35(5): 1164-71.
14. Llovet JM, Real MI, Montana X et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-9.
15. Camma C, Schepis F, Orlando A et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: metaanalysis of randomised controlled trials. Radiology 2002; 224(1): 47-54.
16. Llovet JM, Bruix J. Systematic review of randomised trials for hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37(2): 429-42.
17. Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000; 89(12): 2606-12.
18. Graziadei IW, Sandmueller H, Waldenberger P et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9(6): 557-63.
19. Livraghi T, Giorgio A, Marin G et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197(1): 101-8.
20. Tanaka K, Okazaki H, Nakamura S et al. Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1991; 179(3): 713-7.
21. Tanaka K, Nakamura S, Numata K et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 1992; 185(2): 457-60.
22. Bartolozzi C, Lencioni R, Caramella D et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197(3): 812-8.
23. Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228(1): 235-40.
24. Pacella CM, Bizzarri G, Celloni P et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219(3): 669-78.
25. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002; 94(6): 1747-52.
26. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002; 38(7): 1023-33.
27. Wallace S, Carrasco CH, Charnsangavej C, Richli WR, Wright K, Gianturco C. Hepatic artery infusion and chemoembolisation in the treatment of liver metastases. Cardiovasc Intervent Radiol 1990; 13(3): 153-60.
28. Jaeck D, Bachellier P, Nakano H et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 2003; 185(3): 221-9.
29. Hemming AW, Reed AI, Howard RJ et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237(5): 686-91.
30. Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness - study in 26 patients. Radiology 2003; 227(1): 251-60.
31. Hunt TM, Flowerdew AD, Birch SJ, Williams JD, Mullee MA, Taylor I. Prospective randomised trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990; 77(7): 779-82.
32. Salman HS, Cynamon J, Jagust M et al. Randomized phase II trial of embolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2002; 2(3): 173-9.
33. Lang EK, Brown CL Jr. Colorectal metastases to the liver: selective chemoembolization. Radiology 1993; 189(2): 417-22.
34. Taniai N, Onda M, Tajiri T et al. Good embolization response for colorectal liver metastases with hypervascularity. Hepatogastroenterology 2002; 49(48): 1531-4.
35. Vogl TJ, Mack MG, Balzer JO et al. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 2003; 229(2): 457-64.
36. Elias D, De Baere T, Roche A, Mducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86: 784-8.
37. Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumours. Surg Oncol Clin N Am 2003; 12(1): 231-42.
38. Chamberlain RS, Canes D, Brown KT et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 2000; 190(4): 432-45.
39. Mitty HA, Warner RR, Newman LH, Train JS, Parnes IH. Control of carcinoid syndrome with hepatic artery embolization. Radiology 1985; 155(3): 623-6.
40. Carrasco CH, Charnsangavej C, Ajani J, Samaan NA, Richli W, Wallace S. The carcinoid syndrome: palliation by hepatic artery embolization. AJR Am J Roentgenol 1986; 147(1): 149-54.
41. Hajarizadeh H, Ivancev K, Mueller CR, Fletcher WS, Woltering EA. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg 1992; 163(5): 479-83.
42. Therasse E, Breittmayer F, Roche A et al. Transcatheter chemoembolization of progressive carcinoid liver metastases. Radiology 1993; 189(2): 541-7.
43. Moertel CG, Johnson CM, McKusick MA et al. The management of patients with advanced carcinoid tumours and islet cell tumours. Ann Intern Med 1994; 120(4): 302-9.
44. Perry LJ, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolization for metastatic neuroendocrine tumours. Surgery 1994; 116(6): 1111-6.
45. Diaco DS, Hajarizadeh H, Mueller CR, Fletcher WS, Pommier RF, Woltering EA. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intraarterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg 1995; 169(5): 523-8.
46. Diamandidou E, Ajani JA, Yang DJ et al. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol 1998; 170(2): 339-44.
47. Eriksson BK, Larsson EG, Skogseid BM, Lofberg AM, Lorelius LE, Oberg KE. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumours. Cancer 1998; 83(11): 2293-301.
48. Brown KT, Koh BY, Brody LA et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Intervent Radiol 1999; 10(4): 397-403.
49. Dejong CH, Parks RW, Currie E, Piris J, Redhead DN, Garden OJ. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience. J R Coll Surg Edinb 2002; 47(2): 495-9.
50. Roche A, Girish BV, de Baere T et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumours. Eur Radiol 2003; 13(1): 136-40.
51. Loewe C, Schindl M, Cejna M, Niederle B, Lammer J, Thurnher S. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol 2003; 180: 1379-84.
52. Roy C, Tuchmann C, Morel M, Saussine C, Jacqmin D, Tongio J. Is there still a place for angiography in the management of renal mass lesions? Eur Radiol 1999; 9(2): 329-35.
53. Kaisary AV, Williams G, Riddle PR. The role of preoperative embolization in renal cell carcinoma. J Urol 1984; 131(4): 641-6.
54. Bakke A, Goethlin J, Hoisaeter PA. Renal malignancies: outcome of patients in stage 4 withor without embolization procedure. Urology 1985; 26(6): 541-3.
55. Fischedick AR, Peters PE, Kleinhans G, Pfeifer E. Preoperative renal tumor embolization. A useful procedure? Acta Radiol 1987; 28(3): 303-6.
56. Lanigan D, Jurriaans E, Hammonds JC, Wells IP, Choa RG. The current status of embolization in renal cell carcinoma - a survey of local and national practice. Clin Radiol 1992; 46(3): 176-8.
57. Bakal CW, Cynamon J, Lakritz PS, Sprayregen S. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Intervent Radiol 1993; 4(6): 727-31.
58. Munro NP, Woodhams S, Nawrocki JD, Fletcher M, Thomas PJ. The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int 2003; 92(3): 240-4.
59. Onishi T, Oishi Y, Suzuki Y, Asano K. Prognostic evaluation of transcatheter arterial embolization for unresectable renal cell carcinoma with distant metastases. BJU Int 2001; 87(4): 312-5.
60. Sene AP, Hunt L, McMahon RF, Carroll RN. Renal cell carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 1992; 70(2): 125-34.
61. Park JH, Kim SH, Han JK, Chung JW, Han MC. Transcatheter arterial embolization of unresectable renal cell carcinoma with a mixture of ethanol and iodised oil. Cardiovasc Intervent Radiol 1994; 17(6): 323-7.
62. Kauffmann GW, Richter GM, Rohrbach R, Wenz W. Prolonged survival following palliative renal tumor embolization by capillary occlusion. Cardiovasc Intervent Radiol 1989; 12(1): 22-8.
63. Nickolisen R, Fallon B. Locally recurrent hypernephroma treated by radiation therapy and embolization. A report of two cases. Cancer 1985; 56(5): 1049-51.
64. Stepanek E, Joseph S, Campbell P, Porte M. Embolization of a limb metastasis in renal cell carcinoma as a palliative treatment of bone pain. Clin Radiol 1999; 54(12): 855-7.
65. Yilmaz S, Sindel T, Luleci E. Repeated palliative embolization of renal cell carcinoma metastases. Clin Radiol 2002; 57(4): 855-7 (Letter).
66. Gordon B, Lossof SV, Jelinger E, Barth KH. Embolotherapy for small bowel hemorrhage from metastatic renal cell carcinoma: case report. Cardiovasc Intervent Radiol 1991; 14(5): 311-3.
67. Lammer J, Justich E, Schreyer H, Pettek R. Complications of renal tumor embolization. Cardiovasc Intervent Radiol 1985; 8(1): 31-5.
68. Kurth KH, Debruyne FM, Hall RR et al. Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma. Eur Urol 1987; 13(4): 251-5.
69. Swanson DA, Borges PM. Complication of transabdominal radical nephrectomy for renal cell carcinoma. J Urol 1983; 129(4): 704-7.